Who won: Provision of Assay Kits for SCID Evaluation - SPOTit ImmunoIVD

About this contract

Spot-IT Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 3 Screening laboratories. This is essential for NHSE's ongoing newborn screening statutory requirement, and directly impacts on patient care. Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to Immunoivd AB commencing 01.10.2025

Who won contracts like this

• ✓Answer against the marking scheme, not the question text — NHS England scores each response, so map your evidence to the published criteria and weightings.
• ✓Lead with evidenced capability and social value — for public sector work these usually outweigh price.
• ✓Show recent, comparable delivery: name similar public sector contracts you've delivered for public bodies, with measurable outcomes.
• ✓This one's been awarded — but NHS England retenders on a cycle. Get matched the day the next one lands and start your draft early.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources

Similar contracts